With the exception of IDH-mutant gliomas, MGMT promoter methylation status did not correlate with other tested major glioma subtypes (ie, GBM-RTKII, GBM-mesenchymal, GBM-RTKI; not shown). Here, MGMT is linked to central nervous system cancer.